US Food And Drug Administration Approves GSK's Drug For Severe Asthma

by Shirley Johanna on  November 5, 2015 at 5:37 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

The US Food and Drug Administration approved an injectable drug, Nucala from GlaxoSmithKline to treat severe asthma attacks.

The drug has been approved to treat patients 12 years and older who cannot control their asthma with more conventional drug options.
US Food And Drug Administration Approves GSK's Drug For Severe Asthma
US Food And Drug Administration Approves GSK's Drug For Severe Asthma

Nucala will be administered once every four weeks by subcutaneous injection into the upper arm, thigh, or abdomen.

Nucala is a genetically engineered antibody is grown in cells from Chinese hamsters. The drug reduces severe asthma attacks by reducing the levels of white blood cells that contribute to the development of asthma.

Patients are advised to take other medications, including high-dose inhaled corticosteroids and at least one additional asthma drug.

The side effects of the drug include headache, injection site reactions, back pain, and fatigue. Hypersensitivity reactions can occur within hours or days of injection with Nucala.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Drug Toxicity Asthma Why Do We Eat - Nutrition Facts Diet Lifestyle and Heart Disease Signature Drug Toxicity Hunger Fullness and Weight Control Remedies for Seasonal Allergy Relief Label Lingo on Food Items: Decoded Allergy - Symptom Evaluation 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive